[Table/Fig-1]:
n=24* | Mean±SD† | |
---|---|---|
Age | 43-78 | 62.13±10.39 |
Sex | M‡: 13 (54.2%) F§,: 11 (45.8%) | |
Type of vein occlusion | CRVO||: 6 (25%) BRVOζ: 18 (75%) | |
Eye | RE**: 13 (54.2%) LE††: 11 (45.8%) | |
Pre-PSTT BCVA‡‡ (No. Of letters on ETDRS§§ chart) | 14-46 | 30.08±10.16 |
Pre-PSTT||||CMTζζ | 334-789 | 575±131.54 |
*n=Number of eyes, †SD=Standard Deviation, ‡M=Male, §F=Female,
||CRVO=Central Retinal Vein Occlusion, ζBRVO=Branch Retinal Vein Occlusion,
**RE=Right Eye, ††LE=Left Eye, ‡‡BCVA=Best Corrected Visual Acuity,
§§ETDRS=Early Treatment Diabetic Retinopathy Study, ||||PSTT=Posterior Sub–
Tenon Triamcinolone, ζζCMT=Central Macular Thickness